SanofiSNYNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank71
3Y CAGR-24.7%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-24.7%/yr
vs +16.5%/yr prior
Acceleration
-41.3pp
Decelerating
Percentile
P71
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 6.06% |
| 2024 | 13.63% |
| 2023 | 0.09% |
| 2022 | 14.21% |
| 2021 | 2.93% |
| 2020 | -8.14% |
| 2019 | 2.14% |
| 2018 | 7.71% |
| 2017 | 5.80% |
| 2016 | 1.77% |